MACROGENICS, INC. Earnings Per Share, Basic and Diluted
MACROGENICS, INC. (MGNX) reported Earnings Per Share, Basic and Diluted of -$0.90 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-04-29
- MACROGENICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.90.
- MACROGENICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.66.
- MACROGENICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.94.
- MACROGENICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.91.
- MACROGENICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.54.
- MACROGENICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.69.
- MACROGENICS, INC. earnings per share, basic and diluted for fiscal 2015 was -$0.63.
- MACROGENICS, INC. earnings per share, basic and diluted for fiscal 2014 was -$1.40.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.90 10-Q · filed 2021-04-29 | |||
| 2020-09-30 | -$0.66 10-Q · filed 2020-11-04 | -$2.49 10-Q · filed 2020-11-04 | ||
| 2020-06-30 | -$0.94 10-Q · filed 2020-07-31 | -$1.85 10-Q · filed 2020-07-31 | ||
| 2020-03-31 | -$0.91 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | -$0.62 10-K · filed 2020-02-25 | |||
| 2019-09-30 | -$0.91 10-Q · filed 2020-11-04 | -$2.54 10-Q · filed 2020-11-04 | ||
| 2019-06-30 | -$0.65 10-Q · filed 2020-07-31 | -$1.63 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | -$0.99 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | -$1.06 10-K · filed 2020-02-25 | |||
| 2018-09-30 | -$0.81 10-K · filed 2020-02-25 | -$3.13 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | -$1.03 10-K · filed 2020-02-25 | -$2.35 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | -$1.34 10-K · filed 2020-02-25 | |||
| 2017-12-31 | -$0.54 10-K · filed 2018-02-27 | |||
| 2017-09-30 | -$1.28 10-Q · filed 2018-11-07 | -$3.50 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$1.14 10-Q · filed 2018-08-07 | -$2.21 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$1.08 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | -$1.69 10-K · filed 2018-02-27 | |||
| 2016-09-30 | -$0.97 10-Q · filed 2017-11-08 | -$0.69 10-Q · filed 2017-11-08 | ||
| 2016-03-31 | -$0.88 10-Q · filed 2017-05-03 | |||
| 2015-12-31 | -$0.63 10-K · filed 2018-02-27 | |||
| 2014-12-31 | -$1.40 10-K · filed 2017-02-28 | |||
| 2014-06-30 | -$0.44 derived: net income ÷ weighted average shares · filed 2014-08-05 | -$0.57 derived: net income ÷ weighted average shares · filed 2014-08-05 | ||
| 2014-03-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2014-05-06 | |||
| 2013-12-31 | -$0.04 10-K · filed 2016-02-29 | |||
| 2013-06-30 | -$0.24 derived: net income ÷ weighted average shares · filed 2014-08-05 | -$3.09 derived: net income ÷ weighted average shares · filed 2014-08-05 | ||
| 2013-03-31 | -$2.93 derived: net income ÷ weighted average shares · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |